Mohammad Mazidi
۱۸ مقاله۶ نشریهسالهای فعالیت: ۲۰۰۸–۲۰۲۰
- Radiopharmaceutical Research and Development Lab, Nuclear Science and Technology Research Institute, Atomic Energy Organization of Iran (AEOI), Tehran, Iran (۲۰۱۲–۲۰۲۰)
- Radiation Application Research School, Nuclear Science and Technology Research Institute, Tehran, Iran (۲۰۱۶)
- Radiation Application Research School, Nuclear Science and Technology Research Institute, AEOI, Tehran, Iran (۲۰۱۸)
20082020
مقالهها (۱۸)
Preclinical study of a new 177Lu-labeled somatostatin receptor antagonist in HT-29 human colorectal cancer cells
Histological assessment of intera articular injection of 90Y- hydroxyapatite radiocolloid in enrofloxacin induced rheumatoid arthritis in rat models
Evaluation of [18F]FPTT Molecular structure and its binding to progesterone receptor (PR) for PET scan of breast cancer FPTT Molecular structure and its binding to progesterone receptor (PR) for PET scan of breast cancer
Biodistribution of Tc-99m Labeled Isoniazid Solid Lipid Nanoparticles in Wistar Rats
Biodistribution of Tc-99m Labeled Isoniazid Solid Lipid Nanoparticles in Wistar Rats
Preclinical evaluation of 68Ga-MAA from commercial available 99mTc-MAA kit
Preclinical evaluation of 68Ga-MAA from commercial available 99mTc-MAA kit
Preclinical studies of 166Ho-chitosan for treatment of hepatocellular carcinoma
Optimized preparation and evaluation of 99mTc-Streptomycin
Preparation and quality control of 177Lu-chitosan for radiosynovectomy
Radiosynthesis of 191Os-2-acetylpyridine thiosemicarbazone complex, as an in vivo therapeutic radionuclide generator
Preparation and quality control of scandium-46 bleomycin as a possible therapeutic agent
Preparation and evaluation of 67Ga-DOTA-Bombesin (7-14) as a tumor scintigraphic agent
Production and quality control of 166Ho-Chitosan for therapeutic applications
Development of Sm-153 chitosan for radiosynovectomy
Synthesis and evaluation of a new radiolabeled bombesin analogue for diagnosis of GRP receptor expressing tumors
Synthesis, labeling and quality control of a new Neuropeptide Y analogue for diagnosis of breast tumors
New peptide based freeze-dried kit [99mTc-HYNIC]-UBI 29-41 as a human specific infection imaging agent